
The price set by the Swiss drugmaker Novartis may be the world’s highest for a single treatment — prompting renewed debate about how society will pay for gene-therapy breakthroughs. KATIE THOMAS https://nyti.ms/2HYjDo2 http://bit.ly/2HB4ydf The New York Times Health Drugs (Pharmaceuticals), Health Insurance and Managed Care, Genetic Engineering, Prices (Fares, Fees and Rates), your-feed-healthcare May 24, 2019 at 12:00AM
Comments
Post a Comment